These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24824061)

  • 1. Functionalized mesoporous silica nanoparticles with mucoadhesive and sustained drug release properties for potential bladder cancer therapy.
    Zhang Q; Neoh KG; Xu L; Lu S; Kang ET; Mahendran R; Chiong E
    Langmuir; 2014 Jun; 30(21):6151-61. PubMed ID: 24824061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
    Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
    Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.
    Xie Z; Gong H; Liu M; Zhu H; Sun H
    J Biomater Sci Polym Ed; 2016; 27(1):55-68. PubMed ID: 26540096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
    Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
    J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe
    Abedi M; Abolmaali SS; Abedanzadeh M; Borandeh S; Samani SM; Tamaddon AM
    Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109922. PubMed ID: 31499936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery.
    He H; Xiao H; Kuang H; Xie Z; Chen X; Jing X; Huang Y
    Colloids Surf B Biointerfaces; 2014 May; 117():75-81. PubMed ID: 24632033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
    Zheng J; Tian X; Sun Y; Lu D; Yang W
    Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid nanoparticles for drug delivery and bioimaging: mesoporous silica nanoparticles functionalized with carboxyl groups and a near-infrared fluorescent dye.
    Xie M; Shi H; Ma K; Shen H; Li B; Shen S; Wang X; Jin Y
    J Colloid Interface Sci; 2013 Apr; 395():306-14. PubMed ID: 23394807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
    Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
    Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A general strategy for dual-triggered combined tumor therapy based on template semi-graphitized mesoporous silica nanoparticles.
    Wang Y; Wang K; Yan X; Huang R
    Adv Healthc Mater; 2014 Apr; 3(4):485-9. PubMed ID: 23997032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
    Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
    Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics.
    Lee CH; Cheng SH; Huang IP; Souris JS; Yang CS; Mou CY; Lo LW
    Angew Chem Int Ed Engl; 2010 Oct; 49(44):8214-9. PubMed ID: 20865709
    [No Abstract]   [Full Text] [Related]  

  • 18. A dual-responsive mesoporous silica nanoparticle for tumor-triggered targeting drug delivery.
    Xiao D; Jia HZ; Zhang J; Liu CW; Zhuo RX; Zhang XZ
    Small; 2014 Feb; 10(3):591-8. PubMed ID: 24106109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facile Synthesis of Core-shell Magnetic Mesoporous Silica Nanoparticles for pH-sensitive Anticancer Drug Delivery.
    Shao D; Wang Z; Dong WF; Zhang X; Zheng X; Xiao XA; Wang YS; Zhao X; Zhang M; Li J; Huo QS; Chen L
    Chem Biol Drug Des; 2015 Dec; 86(6):1548-53. PubMed ID: 26216620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.